SOUTH SAN FRANCISCO, Calif., June 05, 2025--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the launch of its Single-Cell Genotype ...
Analysis of published gene sets corroborated these findings: higher stem-like and WNT signaling activity was associated with ...
New data showing rapid and durable full-length MECP2 expression in vivo with single-stranded AAV support improvements ...
PHILADELPHIA--(BUSINESS WIRE)--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 ...
A Cambridge, Massachusetts biotechnology company dosed the first child in the world to receive an experimental gene therapy targeting GJB2 — the single most common genetic cause of childhood deafness ...
A red-shifted fungal luciferase paired with a green reporter lets researchers measure gene activity in glowing plants by ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the ddSEQ™ Single-Cell 3' RNA-Seq Kit and ...
Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), announced its launch and an initial closing of $54 million in Series A ...
The cell and gene therapy field is, some say, at a tipping point—poised to take off. The FDA has noted that, by next year, they aim to approve 10–20 new cell and gene therapies per year. To do that, ...
– Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results